COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation
Abstract Since the onset of the COVID-19 outbreak, numerous articles have highlighted a possible link between COVID-19 vaccination or infection and Herpesviridae co-infection or reactivation. The authors conducted an exhaustive literature review on this topic, the results of which are presented indi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Dermatologia
2023-06-01
|
Series: | Anais Brasileiros de Dermatologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000300347&tlng=en |
_version_ | 1827912684236963840 |
---|---|
author | Alba Navarro-Bielsa Tamara Gracia-Cazaña Beatriz Aldea-Manrique Isabel Abadías-Granado Adrián Ballano Isabel Bernad Yolanda Gilaberte |
author_facet | Alba Navarro-Bielsa Tamara Gracia-Cazaña Beatriz Aldea-Manrique Isabel Abadías-Granado Adrián Ballano Isabel Bernad Yolanda Gilaberte |
author_sort | Alba Navarro-Bielsa |
collection | DOAJ |
description | Abstract Since the onset of the COVID-19 outbreak, numerous articles have highlighted a possible link between COVID-19 vaccination or infection and Herpesviridae co-infection or reactivation. The authors conducted an exhaustive literature review on this topic, the results of which are presented individually for each member of the Herpesviridae family: Herpes Simplex Virus (HSV) types-1 (HSV-1) and 2 (HSV-2); Varicella-Zoster Virus (VZV); Epstein-Barr Virus (EBV); Cytomegalovirus (CMV); HHV-6; HHV-7; and HHV-8. These human herpesviruses can serve as prognostic markers for the COVID-19 infection and may even underlie some of the clinical manifestations initially attributed to SARS-CoV-2. In addition to SARS-CoV-2 infection, all corresponding vaccines approved to date in Europe appear capable of inducing herpesvirus reactivation. It is important to consider all viruses of the Herpesviridae family when managing patients infected with or recently vaccinated against COVID-19. |
first_indexed | 2024-03-13T02:19:08Z |
format | Article |
id | doaj.art-8bca038ab9db487f8015a5bef1e5882c |
institution | Directory Open Access Journal |
issn | 0365-0596 |
language | English |
last_indexed | 2024-03-13T02:19:08Z |
publishDate | 2023-06-01 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | Article |
series | Anais Brasileiros de Dermatologia |
spelling | doaj.art-8bca038ab9db487f8015a5bef1e5882c2023-06-30T10:50:00ZengSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia0365-05962023-06-0198334735410.1016/j.abd.2022.09.004COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivationAlba Navarro-Bielsahttps://orcid.org/0000-0003-1171-6007Tamara Gracia-Cazañahttps://orcid.org/0000-0002-0523-2076Beatriz Aldea-Manriquehttps://orcid.org/0000-0002-2458-0033Isabel Abadías-Granadohttps://orcid.org/0000-0002-5301-1059Adrián Ballanohttps://orcid.org/0000-0001-6256-183XIsabel Bernadhttps://orcid.org/0000-0003-1480-3085Yolanda Gilabertehttps://orcid.org/0000-0001-8034-3617Abstract Since the onset of the COVID-19 outbreak, numerous articles have highlighted a possible link between COVID-19 vaccination or infection and Herpesviridae co-infection or reactivation. The authors conducted an exhaustive literature review on this topic, the results of which are presented individually for each member of the Herpesviridae family: Herpes Simplex Virus (HSV) types-1 (HSV-1) and 2 (HSV-2); Varicella-Zoster Virus (VZV); Epstein-Barr Virus (EBV); Cytomegalovirus (CMV); HHV-6; HHV-7; and HHV-8. These human herpesviruses can serve as prognostic markers for the COVID-19 infection and may even underlie some of the clinical manifestations initially attributed to SARS-CoV-2. In addition to SARS-CoV-2 infection, all corresponding vaccines approved to date in Europe appear capable of inducing herpesvirus reactivation. It is important to consider all viruses of the Herpesviridae family when managing patients infected with or recently vaccinated against COVID-19.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000300347&tlng=enCoinfectionCOVID-19Herpesvirus 1, humanHerpesvirus 2, humanLatent infection |
spellingShingle | Alba Navarro-Bielsa Tamara Gracia-Cazaña Beatriz Aldea-Manrique Isabel Abadías-Granado Adrián Ballano Isabel Bernad Yolanda Gilaberte COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation Anais Brasileiros de Dermatologia Coinfection COVID-19 Herpesvirus 1, human Herpesvirus 2, human Latent infection |
title | COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation |
title_full | COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation |
title_fullStr | COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation |
title_full_unstemmed | COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation |
title_short | COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation |
title_sort | covid 19 infection and vaccines potential triggers of herpesviridae reactivation |
topic | Coinfection COVID-19 Herpesvirus 1, human Herpesvirus 2, human Latent infection |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000300347&tlng=en |
work_keys_str_mv | AT albanavarrobielsa covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT tamaragraciacazana covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT beatrizaldeamanrique covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT isabelabadiasgranado covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT adrianballano covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT isabelbernad covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation AT yolandagilaberte covid19infectionandvaccinespotentialtriggersofherpesviridaereactivation |